Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.

By M. Takemoto, J. Liao. Arteriosclerosis, Thrombosis and Vascular Biology, 2001

1,338 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology, Surgery

View Paper: https://www.semanticscholar.org/paper/5f9124028b8f987d4da1c50dae9ef8cfcac7ec60

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Antonio Ceriello

In Molecular Biology

1. D. Yellon
2. D. Hausenloy
3. Antonio Ceriello
4. E. Murphy
5. C. Steenbergen
6. M. Mocanu

In Surgery

1. Antonio Ceriello

Citations in the corpus

• New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. (2004, background): “In addition to its cholesterol-lowering effect, this class of drugs has been associated with many pleiotropic effects, many of which mediate their cardio-protective effect [98].”
• New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. (2003, background): “It is now evident that thiazolinediones (72), statins (73), ACE inhibitors (74), and ATI inhibitors (75,76) have a strong intracellular antioxidant activity, and it has been suggested that many of their beneficial ancillary effects are due to this property.”